Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Kleiner Perkins Caufield & Byers
Biotech
Sanofi-backed Expansion nabs $80M for RNA neurodegenerative work
Expansion Therapeutics wants to go up against Dyne, Locanabio in myotonic dystrophy. The Sanofi, Novartis-backed biotech now has $80M for the rivalry.
Kyle LaHucik
Sep 29, 2021 7:00am
ArsenalBio joins next-gen cell therapy field with $85M A round
Oct 17, 2019 7:00am
Kleiner, GV drive gene editing startup Trucode to $34M round
Sep 10, 2019 8:30am
Stroke software builder Viz.ai brings in $21M in series A round
Jul 18, 2018 3:30pm
Tmunity dials series A round up to $135M
Apr 19, 2018 9:15am
Armo taps Celgene, GV for $67M to fuel late-phase I-O R&D
Aug 30, 2017 9:09am
